Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abcellera Biologics Inc

ABCL
Current price
4.83 USD +0.15 USD (+3.21%)
Last closed 4.71 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 285 452 928 USD
Yield for 12 month -62.00 %
Week
Month
Year
ABCL
21.11.2021 - 28.11.2021

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada. Address: 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1

Analytics

WallStreet Target Price

22 USD

P/E ratio

Dividend Yield

Current Year

+485 424 000 USD

Last Year

+11 611 543 USD

Current Quarter

+6 599 000 USD

Last Quarter

+10 056 000 USD

Current Year

+418 988 000 USD

Last Year

+11 611 543 USD

Current Quarter

+6 599 000 USD

Last Quarter

+10 056 000 USD

Key Figures ABCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -178 286 000 USD
Operating Margin TTM -831.79 %
PE Ratio
Return On Assets TTM -8.18 %
PEG Ratio
Return On Equity TTM -10.62 %
Wall Street Target Price 22 USD
Revenue TTM 50 391 000 USD
Book Value 4.08 USD
Revenue Per Share TTM 0.18 USD
Dividend Share
Quarterly Revenue Growth YOY -93.5 %
Dividend Yield
Gross Profit TTM 311 109 000 USD
Earnings Share -0.44 USD
Diluted Eps TTM -0.44 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 45.9 %
Profit Margin -256.28 %

Dividend Analytics ABCL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ABCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ABCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 27.4725
Enterprise Value Revenue 3.4915
Price Sales TTM 4.9327
Enterprise Value EBITDA 5.6146
Price Book MRQ 2.3182

Financials ABCL

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ABCL

For 52 weeks

3.87 USD 14 USD
50 Day MA 4.44 USD
Shares Short Prior Month 26 368 364
200 Day MA 6.35 USD
Short Ratio 18.06
Shares Short 27 808 052
Short Percent 13.34 %